http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09506111-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4427 |
filingDate | 1995-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1997-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H09506111-A |
titleOfInvention | Imidazole derivative and method for producing the same |
abstract | (57) [Summary] The novel imidazole derivative of the following formula (I) effectively inhibits the action of angiotensin II and has excellent antihypertensive activity: In the above formula, A is a linear, branched or cyclic C 1 -C 6 alkyl group, or OR 1 (wherein R 1 is H or a linear, branched or cyclic C 1 -C 6 alkyl radical. It is in a); B is a halogen, CF 3 or CF 2 CF 3; X is N or N- oxide; Y is -CH 2 -, - CH (oR 1) - ( wherein, R 1 is as defined above), or -C (= O) - and is; n is 0 or an integer of 1 to 4; Z is halogen, -OH, -OR 1, -NR 1 R 2, -N (= O) R 3 R 4, -C (= O) R 1, -C (= O) oR 1, -CH (oR 1) 2 or -C (= O) NR 1 R 2 ( wherein , R 1 is as defined above, R 2 is independently H or a linear, branched or cyclic C 1 -C 6 alkyl radical, with respect to R 1, R 3 Oyo R 4 is independently linear, be a a) branched or cyclic C 1 -C 6 alkyl radical; D is H or a linear, branched or cyclic C 1 -C 6 alkyl radical. |
priorityDate | 1994-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.